Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial Based on the Theory of Planned Behavior

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, accounting for about 25% and 33% of the world's adult population and Iranians, respectively. There is currently no effective therapeutic agent available for the treatment of NAFLD. However, lifestyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mobasheri, Narges, Ghahremani, Leila, Fallahzadeh Abarghooee, Ebrahim, Hassanzadeh, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484896/
https://www.ncbi.nlm.nih.gov/pubmed/36132088
http://dx.doi.org/10.1155/2022/3465980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484896/
https://www.ncbi.nlm.nih.gov/pubmed/36132088
http://dx.doi.org/10.1155/2022/3465980

Ejemplares similares